Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Athersys, Inc. (ATHX)

(Delayed Data from NSDQ)

$1.55 USD

+0.04 (2.65%)

Updated May 3, 2019 04:00 PM ET

After-Market: $1.55 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.03%
2	Buy	17.70%
3	Hold	9.37%
4	Sell	5.03%
5	Strong Sell	2.48%
S&P	500	11.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Athersys, Inc. [ATHX]

Reports for Purchase

Showing records 1 - 20 ( 40 total )

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 1

08/16/2022

Pages: 4

Termination of Coverage

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 2

06/16/2022

Pages: 7

We Listened to the KOL Panel Diuscussion on Stroke

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 3

06/10/2022

Pages: 7

Increasing the Risk in Stroke Which Further Reduces our Price Target: $5.0 to $3.0

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 4

05/31/2022

Pages: 7

What Does the Data Analysis Really Suggest?

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 5

05/20/2022

Pages: 8

Healios Fails to Meet its Primary Endpoint in the Japan Stroke Trial; Is Age a Confounding Factor? Maybe.

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 6

05/06/2022

Pages: 8

Athersys Reports the Quarter - No Call as We Wait for TREASURE Stroke Data from Healios in Japan

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 7

04/04/2022

Pages: 8

Mixed Message:Treasure on Track, ARDS A?int

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 8

03/31/2022

Pages: 7

What Does the Data Analysis Really Suggest?

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 9

03/16/2022

Pages: 8

Athersys Introduces New CEO to the Street

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 10

01/21/2022

Pages: 8

A new CEO with Commercial Expierence

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 11

12/31/2021

Pages: 8

2022 is Shaping Up as a Year of Transition

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 12

11/16/2021

Pages: 8

Reports the Quarter as We Move Closer to Data

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 13

11/12/2021

Pages: 8

Healios Updates the Timeline

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 12.50

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 14

09/28/2021

Pages: 10

ValuEngine Detailed Valuation Report for ATHX

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 15

08/10/2021

Pages: 7

Reports the Quarter- Raises Capital

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 16

05/07/2021

Pages: 7

Reports the Quarter Next Stop -Japan Data

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 17

03/31/2021

Pages: 8

Partner Healios Completes Enrollment

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 18

03/26/2021

Pages: 8

Athersys Ends the Year with $51M in Cash

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 19

02/17/2021

Pages: 8

Management Transitions with an Eye to Commercialization

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

Company: Athersys, Inc.

Industry: Medical - Biomedical and Genetics

Record: 20

12/21/2020

Pages: 8

Differences: MultiStem Vs. Remestemcel

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: KOLBERT J

Price: 25.00

Research Provided by a Third Party

previous
1
2
next

// eof